Aktsia Arbutus Biopharma Corp (ABUS) hind ja uudised

AvalehtABUS • NASDAQ

Arbutus Biopharma Corp

4,26 $

16. märts, 08:20:34 GMT −4 · USD · NASDAQ · Välistus

AktsiaNoteeritud börsil: USAKoduriik: USA

Viimane sulgemishind

4,26 $

Aasta vahemik

2,71 $ - 5,10 $

Turuväärtus

819,30 mln USD

Keskmine maht

2,67 mln

P/E suhe

Dividendimäär

Põhibörs

NASDAQ

Börsiuudised

GlobeNewswire

16 minuti eest

JFB (NASDAQ: JFB) Announces XTEND and Rayonix Execute

JFB

0,00%

Lexington Herald Leader

38 minuti eest

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

Quipt Home Medical (NASDAQ: QIPT) delists common shares via Form 25

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

How do companies get added to (& dropped from) the Dow? The averages committee explained

.DJI

0,00%

Teave

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Tegevjuht

William H. Collier

Asutatud

2007

Peakontor

Warminster Township, Pennsylvania
Ameerika Ühendriigid

Veebisait

arbutusbio.com

Töötajate arv